Aalen, Germany | 16. May 2022 | ZEISS Vision Care
With its i.Terminal go, ZEISS provides barrier-free centration software for tablets that enables eye care professionals to take a simple first step into digital centration.
The best eyeglass lens can only reach its full potential if it is correctly centered. A digital centration tool can help eye care professionals to deliver data that meet the requirements for customized, ultra-precise quality eyeglass lenses. The ZEISS i.Terminal go provides a smooth transition from manual to digital centration. Only a tablet and the Centration Frame-Clip are needed. No server and additional software have to be installed and no fixed devices set up.
The handling is super simple: the front and side image with the spectacles frame and Centration Frame-Clip is automatically activated when in the correct position and is all that's needed for centration. The distance to the customer, which is often required today, is given because the image can only be taken when a certain distance is maintained. At the end of the procedure the centration parameters can be sent directly to the ZEISS VISUSTORE for ordering the lenses.
- Precise centration combined with a digital customer experience
- Quick and easy image capture
- Rapid and simple calculation of the centration parameters
- Automatic face recognition
- Vergence compensation technology ensures parallel line of sight
- Low entry barriers - only a tablet is needed, Centration Frame-Clip comes with the software
- No additional equipment taking up floor space
The software operation is intuitive and easy to understand so even staff with little previous experience can quickly learn to operate the ZEISS i.Terminal go. If other centration tools are already in use, the ZEISS i.Terminal go can be used as a simple addition on particularly busy days and is ideal to replace the pupillometer.
Anyone in the digital world wanting to offer a professional service to their customers will find the right equipment at ZEISS. ZEISS i.Terminal go can be the optimal entry-level solution for digital centration. Anyone making the additional investment in a server can also archive and retrieve further data with the ZEISS i.Terminal mobile as well as experience an all-round world of service with ZEISS VISUCONSULT 500.
ZEISS i.Terminal 2 is a stationary device and provides a very high standard of accuracy as well as other advantages thanks to patented ZEISS laser technology. It represents the proven centration solution enhancing patient experience. Furthermore, the ZEISS VISUFIT 1000 Platform is ideal for those wanting to lift precision and customer experiences onto a completely new level. Three-dimensional centration is achieved by nine cameras with only one click and no Centration Frame-Clip so consumers can see themselves with the chosen frame from nine different angels. An avatar of the consumer is created which can be subsequently used for the 180° comparison of frames and to simulate different eyeglass lenses, or even try on glasses from home*.
With this range of instruments ZEISS offers the right solution for every level of digitalization and every need. ZEISS i.Terminal go is currently available as a non-medical device in more than ten countries including Brazil, India and Colombia. Availability will be extended to further markets as a medical device in the future.
VISUSTORE, i.Terminal go, i.Terminal mobile, VISUCONSULT 500, i.Terminal 2 and VISUFIT 1000 are registered trademarks of Carl Zeiss Vision GmbH.
*service availability differs between the market
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 7.5 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2021).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.
With over 35,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
Further information at www.zeiss.com
ZEISS Vision Care is one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments. The unit is allocated to the Consumer Markets segment and develops and produces offerings for the entire eyeglass value chain that are distributed globally under the ZEISS brand.